Scientists at Stanford Medicine have uncovered a breakthrough that could reshape how doctors treat joint damage caused by aging and injury. In laboratory studies involving mice and human tissue, researchers found that shutting down a protein linked to aging allowed worn knee cartilage to regenerate and, in some cases, prevented arthritis from developing after serious joint injuries.
The discovery challenges long-held assumptions that cartilage loss is permanent and opens the door to future treatments that could repair joints rather than simply manage pain. If proven effective in people, the approach could eventually reduce the need for knee and hip replacement surgeries, which are currently the last resort for many patients with advanced osteoarthritis.
A Disease With Limited Treatment Options
Osteoarthritis is one of the most common joint disorders worldwide. It develops as cartilage gradually breaks down, leading to stiffness, swelling, and chronic pain that can severely limit mobility. In the United States alone, the condition affects roughly one in five adults and costs the health care system tens of billions of dollars each year.
Despite its prevalence, treatment options remain limited. Most therapies focus on reducing inflammation and discomfort rather than repairing damaged tissue. Once cartilage is lost, the body typically cannot replace it, leaving joint replacement surgery as the only option for severe cases.
The Stanford research team sought to address this gap by focusing on the biological processes that drive cartilage deterioration in the first place.
Targeting a Protein That Increases With Age
The study centers on a protein called 15-hydroxyprostaglandin dehydrogenase, or 15-PGDH. Levels of this protein rise as tissues age, and previous work by the same researchers has shown that it contributes to age-related decline in muscle strength. Because of its role in aging, the team classifies 15-PGDH as a “gerozyme,” a type of enzyme that actively promotes tissue degeneration over time.
In earlier experiments, blocking 15-PGDH helped older mice regain muscle mass and endurance. Encouraged by those results, researchers began investigating whether the same strategy could protect or restore cartilage, which has long been considered incapable of meaningful regeneration.
Unexpected Cartilage Regeneration in Older Mice
To test their theory, scientists compared knee cartilage from young and old mice. As expected, older animals had thinner, weaker cartilage and significantly higher levels of 15-PGDH. When the researchers treated these mice with a drug that inhibits the protein, the results were striking.
Whether the inhibitor was delivered throughout the body or injected directly into the knee joint, cartilage thickness increased across the joint surface. Even more importantly, the new tissue closely resembled healthy hyaline cartilage—the smooth, flexible type that cushions joints and allows them to move easily. This is the same form of cartilage most often damaged by osteoarthritis.
The extent of regeneration surprised the research team, as adult cartilage is typically thought to have very limited healing capacity.
Protecting Joints After Sports-Style Injuries
The researchers also examined whether the treatment could prevent arthritis after knee injuries similar to anterior cruciate ligament tears. Such injuries are common among athletes and physically active individuals and are known to dramatically increase the risk of developing osteoarthritis later in life, even after surgical repair.
In the study, mice with knee injuries were treated with the 15-PGDH inhibitor for several weeks following trauma. Compared with untreated animals, those receiving the drug were far less likely to develop arthritis. They also showed improved movement and placed more weight on the injured leg, suggesting better joint function and reduced discomfort.
In contrast, mice that did not receive the inhibitor showed sharply elevated levels of the aging-linked protein and developed joint degeneration within a short period of time.
Regeneration Without Stem Cells
One of the most surprising aspects of the findings is how the cartilage regenerates. Many tissues rely on stem cells to repair damage, but cartilage behaves differently. The study found no evidence that stem or progenitor cells were responsible for the new cartilage growth.
Instead, existing cartilage cells, known as chondrocytes, changed their behavior. In aging joints, chondrocytes tend to activate genes linked to inflammation, tissue breakdown, and abnormal bone formation. After treatment, those harmful gene patterns declined, while genes associated with healthy cartilage production became more active.
Certain subgroups of chondrocytes linked to cartilage degradation became less common, while cells responsible for maintaining strong, functional cartilage increased significantly. This shift essentially returned the tissue to a more youthful state without relying on new cells.
To explore whether the findings might translate to people, the researchers tested the drug on human cartilage collected during knee replacement surgeries. After just one week of treatment in the lab, the tissue showed reduced signs of degeneration and began forming new articular cartilage.
These results suggest that the same biological pathway operates in human joints, raising hopes that the strategy could one day be used to treat patients suffering from osteoarthritis.
